Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

English version České info

Background:
Few studies have monitored late presentation (LP) of HIV infection over the European continent, including Eastern Europe. Study objectives were to explore the impact of LP on AIDS and mortality.

Methods and Findings:
LP was defined in Collaboration of Observational HIV Epidemiological Research Europe (COHERE) as HIV diagnosis with a CD4 count <350/mm³ or an AIDS diagnosis within 6 months of HIV diagnosis among persons presenting for care between 1 January 2000 and 30 June 2011. Logistic regression was used to identify factors associated with LP and Poisson regression to explore the impact on AIDS/death. 84,524 individuals from 23 cohorts in 35 countries contributed data; 45,488 were LP (53.8%). LP was highest in heterosexual males (66.1%), Southern European countries (57.0%), and persons originating from Africa (65.1%). LP decreased from 57.3% in 2000 to 51.7% in 2010/2011 (adjusted odds ratio [aOR] 0.96; 95% CI 0.95–0.97). LP decreased over time in both Central and Northern Europe among homosexual men, and male and female heterosexuals, but increased over time for female heterosexuals and male intravenous drug users (IDUs) from Southern Europe and in male and female IDUs from Eastern Europe. 8,187 AIDS/deaths occurred during 327,003 person-years of follow-up. In the first year after HIV diagnosis, LP was associated with over a 13-fold increased incidence of AIDS/death in Southern Europe (adjusted incidence rate ratio [aIRR] 13.02; 95% CI 8.19–20.70) and over a 6-fold increased rate in Eastern Europe (aIRR 6.64; 95% CI 3.55–12.43).

Conclusions:
LP has decreased over time across Europe, but remains a significant issue in the region in all HIV exposure groups. LP increased in male IDUs and female heterosexuals from Southern Europe and IDUs in Eastern Europe. LP was associated with an increased rate of AIDS/deaths, particularly in the first year after HIV diagnosis, with significant variation across Europe. Earlier and more widespread testing, timely referrals after testing positive, and improved retention in care strategies are required to further reduce the incidence of LP.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med 10(9): e32767. doi:10.1371/journal.pmed.1001510
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001510

Souhrn

Zdroje

1. GirardiE, AloisiMS, AriciC, PezzottiP, SerrainoD, et al. (2004) Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr 36: 951–959.

2. AntinoriA, CoenenT, CostagiolaD, DedesN, EllefsonM, et al. (2011) Late presentation of HIV infection: a consensus definition. HIV Med 12: 61–64.

3. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach.– 2010 revision. Available: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf. Accessed 23 July 2013.

4. BattegayM, FluckigerU, HirschelB, FurrerH (2007) Late presentation of HIV-infected individuals. Antivir Ther 12: 841–851.

5. SabinCA, SmithCJ, GumleyH, MurphyG, LampeFC, et al. (2004) Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS 18: 2145–2151.

6. LanoyE, Mary-KrauseM, TattevinP, PerbostI, Poizot-MartinI, et al. (2007) Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 12: 89–96.

7. QuinnTC, WawerMJ, SewankamboN, SerwaddaD, LiC, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921–929.

8. European Centre for Disease Prevention and Control. (2010) HIV testing: increasing uptake and effectiveness in the European Union. Available: http://www.ecdc.europa.eu/en/publications/Publications/101129_GUI_HIV_testing.pdf. Accessed 23 July 2013.

9. KrentzHB, GillJ (2010) Despite CD4 cell count rebound the higher initial costs of medical care for HIV-infected patients persist 5 years after presentation with CD4 cell counts less than 350 mul. AIDS 24: 2750–2753.

10. FleishmanJA, YehiaBR, MooreRD, GeboKA (2010) The economic burden of late entry into medical care for patients with HIV infection. Med Care 48: 1071–1079.

11. DeblondeJ, DeKP, HamersFF, FontaineJ, LuchtersS, et al. (2010) Barriers to HIV testing in Europe: a systematic review. Eur J Public Health 20: 422–432.

12. YazdanpanahY, LangeJ, GerstoftJ, CairnsG (2010) Earlier testing for HIV–how do we prevent late presentation? Antivir Ther 15 Suppl 1: 17–24.

13. KjaerJ, LedergerberB (2004) HIV cohort collaborations: proposal for harmonization of data exchange. Antivir Ther 9: 631–633.

14. ZoufalyA, van derHM, MarcusU, HoffmannC, StellbrinkH, et al. (2012) Late presentation for HIV diagnosis and care in Germany. HIV Med 13: 172–181.

15. d'ArminioMA, Cozzi-LepriA, GirardiE, CastagnaA, MussiniC, et al. (2011) Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther 16: 1103–1112.

16. CamoniL, RaimondoM, RegineV, SalfaMC, SuligoiB (2013) Late presenters among persons with a new HIV diagnosis in Italy, 2010–2011. BMC Public Health 13: 281.

17. VivesN, Carnicer-PontD, Garcia deOP, CampsN, EsteveA, et al. (2012) Factors associated with late presentation of HIV infection in Catalonia, Spain. Int J STD AIDS 23: 475–480.

18. HellebergM, EngsigFN, KronborgG, LaursenAL, PedersenG, et al. (2012) Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis 44: 282–288.

19. NdiayeB, SalleronJ, VincentA, BatailleP, BonnevieF, et al. (2011) Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997–2007. BMC Infect Dis 11: 11.

20. European Centre for Disease Prevention and Control/WHO RegionalOffice for Europe (2009) HIV/AIDS surveillance in Europe 2009. Available: http://www.ecdc.europa.eu/en/publications/publications/101129_sur_hiv_2009.pdf. Accessed 23 July 2013.

21. World Health Organization (2007) Guidance on provider-initiated HIV testing and counselling in health facilities. Available: http://whqlibdoc.who.int/publications/2007/9789241595568_eng.pdf. Accessed 23 July 2013.

22. de OlallaPG, ManzardoC, SambeatMA, OcanaI, KnobelH, et al. (2011) Epidemiological characteristics and predictors of late presentation of HIV infection in Barcelona (Spain) during the period 2001–2009. AIDS Res Ther 8: 22.

23. CastillaJ, SobrinoP, De La FuenteL, NoguerI, GuerraL, et al. (2002) Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS 16: 1945–1951.

24. CouturierE, SchwoebelV, MichonC, HubertJB, DelmasMC, et al. (1998) Determinants of delayed diagnosis of HIV infection in France, 1993–1995. AIDS 12: 795–800.

25. MathersBM, DegenhardtL, AliH, WiessingL, HickmanM, et al. (2010) HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 375: 1014–1028.

26. DicksonN, McAllisterS, SharplesK, PaulC (2012) Late presentation of HIV infection among adults in New Zealand: 2005–2010. HIV Med 13: 182–189.

27. SullivanAK, RabenD, ReekieJ, RaymentM, MocroftA, et al. (2013) Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS One 8: e52845 doi:10.1371/journal.pone.0052845

28. ChadbornTR, DelpechVC, SabinCA, SinkaK, EvansBG (2006) The late diagnosis and consequent short-term mortality of HIV-infected heterosexuals (England and Wales, 2000–2004). AIDS 20: 2371–2379.

29. SametJH, FreedbergKA, SteinMD, LewisR, SavetskyJ, et al. (1998) Trillion virion delay: time from testing positive for HIV to presentation for primary care. Arch Intern Med 158: 734–740.

30. DelpierreC, Lauwers-CancesV, PuglieseP, Poizot-MartinI, BillaudE, et al. (2008) Characteristics trends, mortality and morbidity in persons newly diagnosed HIV positive during the last decade: the profile of new HIV diagnosed people. Eur J Public Health 18: 345–347.

31. ReekieJ, KowalskaJD, KarpovI, RockstrohJ, KarlssonA, et al. (2012) Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One 7: e41673 doi:10.1371/journal.pone.0041673

32. GirardiE, SabinCA, MonforteAD (2007) Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 46 Suppl 1: S3–S8.

33. JolleyE, RhodesT, PlattL, HopeV, LatypovA, et al. (2012) HIV among people who inject drugs in Central and Eastern Europe and Central Asia: a systematic review with implications for policy. BMJ Open 2.

34. Likatavicius G, van de Laar MJ (2011) HIV infection and AIDS in the European Union and European Economic Area, 2010. Euro Surveill 16. Available: http://www.eurosurveillance.org/images/dynamic/EE/V16N48/art20030.pdf. Accessed 23 July 2013.

35. Global report: UNAIDS report on the global AIDS epidemic (2012). Available: http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/gr2012/20121120_UNAIDS_Global_Report_2012_en.pdf. Accessed 23 July 2013.

36. JohnsonM, SabinC, GirardiE (2010) Definition and epidemiology of late presentation in Europe. Antivir Ther 15 Suppl 1: 3–8.

37. TurnerBJ, CunninghamWE, DuanN, AndersenRM, ShapiroMF, et al. (2000) Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Arch Intern Med 160: 2614–2622.